<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33409823</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>ALS2-related disorders in Spanish children.</ArticleTitle><Pagination><StartPage>2091</StartPage><EndPage>2094</EndPage><MedlinePgn>2091-2094</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04899-0</ELocationID><Abstract><AbstractText>ALS2 gene encoding for alsin protein is responsible for neurological disorders due to retrograde degeneration of the upper motor neurons of the pyramidal tracts, inherited in an autosomal recessive manner, and displaying a clinical continuum including the infantile ascending hereditary spastic paraplegiaidentified in three Spanish children presented here.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nogueira</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0693-4026</Identifier><AffiliationInfo><Affiliation>Molecular Diagnostics Eurofins-Megalab, Hospital San Rafael, Madrid, Spain. enrique.nogueira@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetics Service, Hospital La Zarzuela, Madrid, Spain. enrique.nogueira@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarc&#xf3;n</LastName><ForeName>Juana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pediatric Neurology, Hospital San Rafael, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garma</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Molecular Diagnostics Eurofins-Megalab, Hospital San Rafael, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetics Service, Hospital La Zarzuela, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paredes</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Pediatric Neurology, Hospital San Rafael, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C438187">ALS2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020662">Guanine Nucleotide Exchange Factors</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020662" MajorTopicYN="N">Guanine Nucleotide Exchange Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015419" MajorTopicYN="Y">Spastic Paraplegia, Hereditary</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS2</Keyword><Keyword MajorTopicYN="N">ALS2-related disorders</Keyword><Keyword MajorTopicYN="N">IAHSP</Keyword><Keyword MajorTopicYN="N">Infantile ascending hereditary spastic paraplegia</Keyword><Keyword MajorTopicYN="N">Spanish children</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33409823</ArticleId><ArticleId IdType="pmc">PMC8043897</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04899-0</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04899-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Orrell RW (1993&#x2013;2017) ALS2-related disorders. 2005 Oct 21 [Updated 2016 Jan 28]. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews [Internet]. University of Washington, Seattle. Available from https://www.ncbi.nlm.nih.gov/books/NBK1243. Accessed 8 Nov 2020</Citation></Reference><Reference><Citation>Brugman F, Eymard-Pierre E, van den Berg LH, et al. Adult-onset primary lateral sclerosis is not associated with mutations in the ALS2 gene. Neurology. 2007;69:702&#x2013;704. doi: 10.1212/01.wnl.0000267322.48364.76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000267322.48364.76</ArticleId><ArticleId IdType="pubmed">17698795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, Miyamoto N, Showguchi-Miyata J, Okada Y, Singaraja R, Figlewicz DA, Kwiatkowski T, Hosler BA, Sagie T, Skaug J, Nasir J, Brown RH, Jr, Scherer SW, Rouleau GA, Hayden MR, Ikeda JE. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29:166&#x2013;173. doi: 10.1038/ng1001-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-166</ArticleId><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, Hung WY, Ouahchi K, Yan J, Azim AC, Cole N, Gascon G, Yagmour A, Ben-Hamida M, Pericak-Vance M, Hentati F, Siddique T. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001;29:160&#x2013;165. doi: 10.1038/ng1001-160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-160</ArticleId><ArticleId IdType="pubmed">11586297</ArticleId></ArticleIdList></Reference><Reference><Citation>Eymard-Pierre E, Lesca G, Dollet S, Santorelli FM, di Capua M, Bertini E, Boespflug-Tanguy O. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet. 2002;71:518&#x2013;527. doi: 10.1086/342359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/342359</ArticleId><ArticleId IdType="pmc">PMC379189</ArticleId><ArticleId IdType="pubmed">12145748</ArticleId></ArticleIdList></Reference><Reference><Citation>Devon RS, Helm JR, Rouleau GA, Leitner Y, Lerman-Sagie T, Lev D, Hayden MR. The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings. Clin Genet. 2003;64:210&#x2013;215. doi: 10.1034/j.1399-0004.2003.00138.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-0004.2003.00138.x</ArticleId><ArticleId IdType="pubmed">12919135</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F, Meijer IA, Hand CK, Dub&#xe9; MP, MacGregor DL, Seni MH, Devon RS, Hayden MR, Andermann F, Andermann E, Rouleau GA. An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred. Ann Neurol. 2003;53:144&#x2013;145. doi: 10.1002/ana.10422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10422</ArticleId><ArticleId IdType="pubmed">12509863</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress JA, K&#xfc;hnlein P, Winter P, Ludolph AC, Kassubek J, M&#xfc;ller U, Sperfeld AD. Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann Neurol. 2005;58:800&#x2013;803. doi: 10.1002/ana.20665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20665</ArticleId><ArticleId IdType="pubmed">16240357</ArticleId></ArticleIdList></Reference><Reference><Citation>Eymard-Pierre E, Yamanaka K, Haeussler M, Kress W, Gauthier-Barichard F, Combes P, Cleveland DW, Boespflug-Tanguy O. Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis. Ann Neurol. 2006;59:976&#x2013;980. doi: 10.1002/ana.20879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20879</ArticleId><ArticleId IdType="pubmed">16718699</ArticleId></ArticleIdList></Reference><Reference><Citation>Panzeri C, De Palma C, Martinuzzi A, et al. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain. 2006;129:1710&#x2013;1719. doi: 10.1093/brain/awl104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl104</ArticleId><ArticleId IdType="pubmed">16670179</ArticleId></ArticleIdList></Reference><Reference><Citation>Sztriha L, Panzeri C, K&#xe1;lm&#xe1;nchey R, Szab&#xf3; N, Endreffy E, T&#xfa;ri S, Baschirotto C, Bresolin N, Vekerdy Z, Bassi MT. First case of compound heterozygosity in ALS2 gene in infantile-onset ascending spastic paralysis with bulbar involvement. Clin Genet. 2008;73:591&#x2013;593. doi: 10.1111/j.1399-0004.2008.00993.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2008.00993.x</ArticleId><ArticleId IdType="pubmed">18394004</ArticleId></ArticleIdList></Reference><Reference><Citation>Verschuuren-Bemelmans CC, Winter P, Sival DA, Elting JW, Brouwer OF, M&#xfc;ller U. Novel homozygous ALS2 nonsense mutation (p.Gln715X) in sibs with infantile-onset ascending spastic paralysis: the first cases from northwestern Europe. Eur J Hum Genet. 2008;16:1407&#x2013;1411. doi: 10.1038/ejhg.2008.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2008.108</ArticleId><ArticleId IdType="pubmed">18523452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintchev N, Zamba-Papanicolaou E, Kleopa KA, Christodoulou K. A novel ALS2 splice-site mutation in a Cypriot juvenile-onset primary lateral sclerosis family. Neurology. 2009;72:28&#x2013;32. doi: 10.1212/01.wnl.0000338530.77394.60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000338530.77394.60</ArticleId><ArticleId IdType="pubmed">19122027</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirakawa K, Suzuki H, Ito M, Kono S, Uchiyama T, Ohashi T, Miyajima H. Novel compound heterozygous als2 mutations cause juvenile amyotrophic lateral sclerosis in Japan. Neurology. 2009;73:2124&#x2013;2126. doi: 10.1212/WNL.0b013e3181c67be0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181c67be0</ArticleId><ArticleId IdType="pubmed">20018642</ArticleId></ArticleIdList></Reference><Reference><Citation>Luigetti M, Lattante S, Conte A, Romano A, Zollino M, Marangi G, Sabatelli M. A novel compound heterozygous ALS2 mutation in two Italian siblings with juvenile amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:470&#x2013;472. doi: 10.3109/21678421.2012.756036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.756036</ArticleId><ArticleId IdType="pubmed">23282280</ArticleId></ArticleIdList></Reference><Reference><Citation>Flor-de-Lima F, Sampaio M, Nahavandi N. Alsin related disorders: literature review and case study with novel mutations. Case Rep Genet. 2014;2014:691515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4180207</ArticleId><ArticleId IdType="pubmed">25302125</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi S, Foo JN, Vu A, Azim S, Silver DL, Mansoor A, Tay SKH, Abbasi S, Hashmi AH, Janjua J, Khalid S, Tai ES, Yeo GW, Khor CC. A novel splice-site mutation in ALS2 establishes the diagnosis of juvenile amyotrophic lateral sclerosis in a family with early onset anarthria and generalized dystonias. PLoS One. 2014;9:e113258. doi: 10.1371/journal.pone.0113258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113258</ArticleId><ArticleId IdType="pmc">PMC4256290</ArticleId><ArticleId IdType="pubmed">25474699</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie F, Cen ZD, Xiao JF, Luo W. Novel compound heterozygous ALS2 mutations in two Chinese siblings with infantile ascending hereditary spastic paralysis. Neurol Sci. 2015;36:1279&#x2013;1280. doi: 10.1007/s10072-014-2018-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-014-2018-8</ArticleId><ArticleId IdType="pubmed">25433428</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq H, Mukhtar S, Naz S. A novel mutation in ALS2 associated with severe and progressive infantile onset of spastic paralysis. J Neurogenet. 2017;31:26&#x2013;29. doi: 10.1080/01677063.2017.1324441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01677063.2017.1324441</ArticleId><ArticleId IdType="pubmed">28502191</ArticleId></ArticleIdList></Reference><Reference><Citation>Helal M, Mazaheri N, Shalbafan B, Malamiri RA, Dilaver N, Buchert R, Mohammadiasl J, Golchin N, Sedaghat A, Mehrjardi MYV, Haack TB, Riess O, Chung WK, Galehdari H, Shariati G, Maroofian R. Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant. Neurol Sci. 2018;39:1917&#x2013;1925. doi: 10.1007/s10072-018-3526-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3526-8</ArticleId><ArticleId IdType="pubmed">30128655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato K, Otomo A, Ueda MT, Hiratsuka Y, Suzuki-Utsunomiya K, Sugiyama J, Murakoshi S, Mitsui S, Ono S, Nakagawa S, Shang HF, Hadano S. Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function. J Biol Chem. 2018;293:17135&#x2013;17153. doi: 10.1074/jbc.RA118.003849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003849</ArticleId><ArticleId IdType="pmc">PMC6222102</ArticleId><ArticleId IdType="pubmed">30224357</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>